ChristineNDuncanMD

Pediatric Hematology & Oncology • Boston, MA

Assistant Professor in Pediatrics, Dana-Farber Cancer Institute

Join to view full profile

Dr. Duncan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Duncan's full profile

Already have an account?

Office
44 Binney St
JFC
Boston, MA 02115
Phone+1 617-632-6255

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2003 - 2006
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1999 - 2003
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1999

Certifications & Licensure

FL State Medical License 2022 - Present
ME State Medical License 2022 - 2026
RI State Medical License 2023 - 2026
CT State Medical License 2022 - 2025
MA State Medical License 2002 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies. Start of enrollment: 2012 Jul 01
Terminated
Phase 2
Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita Start of enrollment: 2012 Jul 01
Active, not recruiting
Phase 2
Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes Start of enrollment: 2012 Dec 11
Completed
Phase 2
Feasibility Study of Low Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Transplants Patients Start of enrollment: 2014 Apr 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transpla...
Neel S Bhatt, Andrew C Harris, Lev Gorfinkel, Katarzyna Ibanez, Eric R Tkaczyk
Transplantation and Cellular Therapy. 2025-02-01
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.
Takuto Takahashi, Benjamin Watkins, Brandi Bratrude, Donna Neuberg, Kyle Hebert
Transplantation and Cellular Therapy. 2025-02-01
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transpla...
Seth J Rotz, Lori Wiener, K Scott Baker, Sung Won Choi, Rachel Phelan
Transplantation and Cellular Therapy. 2024-12-27

Journal Articles

Management Guidelines for Paediatric Patients Receiving Chimeric Antigen Receptor T Cell Therapy
Kris M Mahadeo, Julie C Fitzgerald, Marie E Steiner, Partow Kebriaei, Katayoun Rezvani, Ira M Cheifetz, John M Slopis, Paul L Martin, Sattva S Neelapu, Agne Tarasevici..., Nature

Abstracts/Posters

No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Com...
Christine Duncan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Transplant Associated Thrombotic Microangiopathy (TA-TMA): Lessons Learned from a Large Pediatric Center
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Gene Therapy for Adrenoleukodystrophy: Studies Find Both Risks and BenefitsOctober 16th, 2024
NEJM Reports Detail Blood Cancers After Gene Therapy for Cerebral AdrenoleukodystrophyOctober 16th, 2024
Hematologic Cancer Develops in Some Patients Receiving Eli-CelOctober 11th, 2024
Join now to see all